お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
972431

生検装置の世界市場:動向分析・市場競合シナリオ・展望 (2016-2026年)

Global Biopsy Devices Market Size by Product, Application, Imaging Technology, and End User, By Region, (Trend Analysis, Market Competition Scenario & Outlook, 2016-2026.

出版日: | 発行: Blueweave Consulting & Research Private Limited | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
生検装置の世界市場:動向分析・市場競合シナリオ・展望 (2016-2026年)
出版日: 2020年11月01日
発行: Blueweave Consulting & Research Private Limited
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界における生検装置の市場規模は、2020年から2026年にかけて、6%のCAGRで推移すると見込まれ、2019年の25億3000万米ドルから、2026年までに38億米ドルへ達すると予測されています。

がん発生率の増加および診断・治療に対するニーズの拡大は、世界の生検装置市場の発展に寄与しています。また、がん治療・診断に関する認識の高まりも、今後数年間の生検装置市場の成長を支えると見込まれます。

当レポートでは、世界の生検装置市場について調査し、現在の市場動向、市場への影響要因、各セグメント・地域別による市場の分析と予測、および主要企業のプロファイルなどを提供しています。

目次

第1章 調査フレームワーク

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の生検装置市場:業界考察

  • 業界バリューチェーン分析
  • DROC分析
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • 技術情勢
  • 規制の枠組み
  • 企業の市場シェア分析
  • ポーターのファイブフォース分析
  • 戦略的展望

第5章 世界の生検装置市場概要

  • 市場規模・予測:金額ベース
    • 金額ベース
  • 市場シェア・予測
    • 製品別
      • 針ベースの生検装置
      • 生検鉗子
      • 局所ワイヤー
      • その他の製品
    • アプリケーション別
      • 乳房生検
      • 消化器生検
      • 前立腺生検
      • 肝生検
      • 肺生検
      • 腎臓生検
      • 婦人科生検
      • その他
    • イメージング技術別
      • MRIガイド下生検
      • 定位ガイド下生検
      • 超音波ガイド下生検
      • CTスキャン
      • その他
    • エンドユーザー別
      • 診断および画像センター
      • 病院
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ

第6章 北米の生検装置市場

  • 市場規模・予測:金額ベース
    • 金額ベース
  • 市場シェア・予測
    • 製品タイプ別
    • アプリケーション別
    • イメージング技術別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第7章 欧州の生検装置市場

  • 市場規模・予測:金額ベース
    • 金額ベース
  • 市場シェア・予測
    • 製品タイプ別
    • アプリケーション別
    • イメージング技術別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • その他欧州

第8章 アジア太平洋地域の生検装置市場

  • 市場規模・予測:金額ベース
    • 金額ベース
  • 市場シェア・予測
    • 製品タイプ別
    • アプリケーション別
    • イメージング技術別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • アジア太平洋のその他諸国

第9章 南米の生検装置市場

  • 市場規模・予測:金額ベース
    • 金額ベース
  • 市場シェア・予測
    • 製品タイプ別
    • アプリケーション別
    • イメージング技術別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • その他ラテンアメリカ

第10章 中東・アフリカの生検装置市場

  • 市場規模・予測:金額ベース
    • 金額ベース
  • 市場シェア・予測
    • 製品タイプ別
    • アプリケーション別
    • イメージング技術別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • 南アフリカ
      • その他

第11章 企業プロファイル(企業概要、財務マトリックス、製品情勢、主要人物、主要競合他社、連絡先住所、および戦略的見通し)

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company (C.R. Bard, Inc.)
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation (Leica Microsystem)
  • Fujifilm Holdings Corp.
  • Hologic, Inc.
  • Medtronic plc
  • その他

第12章 戦略的推奨事項

目次
Product Code: bwc20164

Global Biopsy Devices Market to witness a surge in its valuation with a 6 % CAGR by 2026

According to BlueWeave Consulting, Global Biopsy Devices Market is estimated to be USD 3.8 billion by 2026 from USD 2.53 billion in 2019, at a CAGR of 6% from 2020 to 2026.

A biopsy is a type of process to eliminate a piece of tissue or a sample of cells from a patient's body. It is majorly used to extract tissue samples for finding and definitively recognize cancerous tissue and cells. The global market for biopsy devices is rising rapidly. The market is increasing the occurrence of cancer and the continually growing need for high-worth diagnostic and therapeutic procedures are majorly accountable for the development of the global biopsy devices market. Also, the rising awareness concerning cancer treatment and diagnosis will support the increase in the biopsy devices market size in the forthcoming years. Many countries hold courses for the early diagnosis of breast cancer. Therefore, such initiatives will accelerate the acceptance rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business in the predictable future. North America is found to be the leading revenue contributor in the market. The well-known market players in the region will continue to account for a considerable share in the market throughout the forecast period.

"The Breast Biopsy dominates the Application Segment"

Based on the application, the market is classified into breast biopsy, gastrointestinal (GI) biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy, and others. Based on the application, the breast biopsy in the application segment generated the highest revenue in 2018 and is expected to maintain its supremacy during the forecast period. This is attributed to the rise in the number of breast cancer patients witnessed over the years throughout the globe and is predictable to maintain this trend in the future. Presently, breast cancer can be recognized efficiently using progressive biopsy devices with higher efficacy in less time. Besides, the surge in the public consciousness for disease screening and technological advancement in biopsy devices has driven the request for the use of biopsy devices universal.

Growth Drivers

Rising cases of cancer

The growing occurrence of cancer universal and the occurrence of untapped opportunities in developing economies, especially of Asia Pacific, along with refining healthcare infrastructure in these regions, are amid the key trends stoking market growth. Surging demand for effective diagnostic procedures for cancer is also predictable to work in favor of the market.

R&D in the medical field

The outline of technologically advanced products such as the Aspiration biopsy syringe gun by INRAD Inc. supports the section's development. Moreover, the burgeoning demand for vacuum-assisted devices is inducing the biopsy devices market positively. These devices are manual, semi-automatic, and automatic with a spring-loaded mechanism for minimally invasive insertion to obtain laboratory testing samples. Such devices prove high efficiency and accuracy in the withdrawal of large volumes and excellent quality tissue samples with minimal passes through the skin.

Continual research and development in medical devices have led to the introduction of various novel gear and systems in the market, such as robotic medical systems. Robotic guidance systems offer multiple welfares in a process such as growing the total number of surgeries executed by a surgeon and reducing patient stay in the hospital. These systems are used to reduce the entire procedural duration to safeguard minimal patient discomfort.

Restraint

Financial constraint

Growing cancer-related expenditure is triggering the need for actual diagnostic procedures. Government and healthcare regulatory bodies worldwide are engaged continuously in curbing high costs related to the treatment of cancer. Primary and secondary healthcare centers in emerging nations are boosting patients to experience regular diagnostic examinations. Biopsy devices involve a comparatively lesser number of hospitals stays and, therefore, is economically viable.

"North America dominates the Global Biopsy Devices Market"

North America occupied the largest share of the market in 2018 and is expected to maintain its dominance during the predicted period owing to extensive accessibility of trained medical professionals, availability of well-developed infrastructure facilities, and the existence of mainstream of crucial players. However, Asia-Pacific is probable to see the highest growth rate throughout the forecast period, due to its large population base, the surge in disposable income, and the rise in patient consciousness toward disease screening. Besides, the increase in the geriatric population that is highly vulnerable to cancer is the crucial funder for its market growth.

Global Biopsy Devices Market: Competitive Landscape

Some of the leading players operating in the Global Biopsy Devices Market are Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc. Other prominent players.

Do not miss the business opportunity of the Global Biopsy Devices Market. Consult our analyst, gain crucial insights, and facilitate your business growth.

The in-depth analysis of the report provides the growth potential, upcoming trends, and statistics of the Global Biopsy Devices Market size & forecast. The report promises to provide state-of-the-art technology of Global Biopsy Devices Market and industry insights, which help decision-makers to make sound strategic decisions. Furthermore, the report also analyzes the market drivers, challenges, and competitive analysis of the market.

About Us

BlueWeave Consulting is a one-stop solution for market intelligence regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality performance and nourishing long-lasting relationships with its clients. We are one of the promising digital market intelligence generation company providing unique solutions for blooming your business and making the morning, more rising & shining.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents
  • 2.5. Market Size Estimation
  • 2.6. Assumption for The Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Biopsy Devices Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape
  • 4.4. Regulatory Framework
  • 4.5. Company Market Share Analysis,2019
  • 4.6. Porter's Five forces analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of New Entrants
    • 4.6.4. Threat of Substitutes
    • 4.6.5. Intensity of Rivalry
  • 4.7. Strategic Outlook

5. Global Biopsy Devices Market Overview

  • 5.1. Market Estimates & Forecast by Value, 2016-2026
    • 5.1.1. By Value (USD)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Needle-Based Biopsy Instruments
      • 5.2.1.2. Biopsy Forceps
      • 5.2.1.3. Localization Wires
      • 5.2.1.4. Other Products
    • 5.2.2. By Application
      • 5.2.2.1. Breast Biopsy
      • 5.2.2.2. Gastroenterology Biopsy
      • 5.2.2.3. Prostate Biopsy
      • 5.2.2.4. Liver Biopsy
      • 5.2.2.5. Lung Biopsy
      • 5.2.2.6. Kidney Biopsy
      • 5.2.2.7. Gynecological Biopsy
      • 5.2.2.8. Others
    • 5.2.3. By Imaging Technology
      • 5.2.3.1. MRI-guided Biopsy
      • 5.2.3.2. Stereotactic-guided Biopsy
      • 5.2.3.3. Ultrasound-guided Biopsy
      • 5.2.3.4. CT scan
      • 5.2.3.5. Others
    • 5.2.4. By End User
      • 5.2.4.1. Diagnostic and Imaging Centers
      • 5.2.4.2. Hospitals
      • 5.2.4.3. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East & Africa

6. North America Biopsy Devices Market

  • 6.1. Market Estimates & Forecast by Value, 2016-2026
    • 6.1.1. By Value (USD)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Imaging Technology
    • 6.2.4. By End User
    • 6.2.5. By Country
      • 6.2.5.1. U.S
      • 6.2.5.2. Canada

7. Europe Biopsy Devices Market

  • 7.1. Market Estimates & Forecast by Value, 2016-2026
    • 7.1.1. By Value (USD)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Imaging Technology
    • 7.2.4. By End User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. U.K
      • 7.2.5.3. France
      • 7.2.5.4. Italy
      • 7.2.5.5. Rest of Europe

8. Asia Pacific Biopsy Devices Market

  • 8.1. Market Estimates & Forecast by Value, 2016-2026
    • 8.1.1. By Value (USD)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Imaging Technology
    • 8.2.4. By End User
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of APAC

9. South America Biopsy Devices Market

  • 9.1. Market Estimates & Forecast by Value, 2016-2026
    • 9.1.1. By Value (USD)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Imaging Technology
    • 9.2.4. By End User
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Argentina
      • 9.2.5.4. Rest of Latin America

10. Middle East & Africa Biopsy Devices Market

  • 10.1. Market Estimates & Forecast by Value, 2016-2026
    • 10.1.1. By Value (USD)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Imaging Technology
    • 10.2.4. By End User
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

* Argon Medical Devices, Inc.

* B. Braun Melsungen AG

* Becton Dickinson and Company (C.R. Bard, Inc.)

* Boston Scientific Corporation

* Cardinal Health, Inc.

* Cook Medical, Inc.

* Danaher Corporation (Leica Microsystem)

* Fujifilm Holdings Corp.

* Hologic, Inc.

* Medtronic plc

* Others

12. Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.